Loading...
Concomitant KRAS and BRAF mutations in colorectal cancer
BRAF and KRAS are two key oncogenes in the RAS/RAF/MEK/MAP-kinase signaling pathway. While previously considered mutually exclusive, concomitant mutations in both KRAS and BRAF genes have been identified in colorectal cancer (CRC). The clinical outcome of these patients remains undetermined. We pres...
Na minha lista:
| Udgivet i: | J Gastrointest Oncol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6534722/ https://ncbi.nlm.nih.gov/pubmed/31183211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2019.01.10 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|